We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBI icon
1601
Pitney Bowes
PBI
$2.28B
$707K ﹤0.01%
97,701
+10,870
+13% +$80.8K
CBRL icon
1602
Cracker Barrel
CBRL
$1.31B
$707K ﹤0.01%
13,371
+754
+6% +$37.3K
MDXG icon
1603
MiMedx Group
MDXG
$624M
$705K ﹤0.01%
73,306
+6,673
+10% +$52K
MD icon
1604
Pediatrix Medical
MD
$2.15B
$703K ﹤0.01%
53,552
+3,419
+7% +$47.2K
SPHR icon
1605
Sphere Entertainment
SPHR
$6.33B
$701K ﹤0.01%
17,387
+1,229
+8% +$51.4K
CARS icon
1606
Cars.com
CARS
$648M
$701K ﹤0.01%
40,450
+1,976
+5% +$34.5K
GABC icon
1607
German American Bancorp
GABC
$1.91B
$699K ﹤0.01%
17,387
+878
+5% +$37.2K
SUI icon
1608
Sun Communities
SUI
$14.4B
$699K ﹤0.01%
5,683
-35
-0.6% -$4.48K
SLNO
1609
DELISTED
Soleno Therapeutics
SLNO
$698K ﹤0.01%
15,539
+2,767
+22% +$143K
JAMF
1610
DELISTED
Jamf
JAMF
$698K ﹤0.01%
49,651
+3,217
+7% +$50.7K
WVE icon
1611
Wave Life Sciences
WVE
$1.02B
$692K ﹤0.01%
55,941
+12,340
+28% +$165K
NTST
1612
NETSTREIT Corp
NTST
$2.08B
$692K ﹤0.01%
48,896
+3,961
+9% +$61.6K
BBSI icon
1613
Barrett Business Services
BBSI
$756M
$692K ﹤0.01%
15,923
+1,347
+9% +$54.4K
CSR
1614
Centerspace
CSR
$925M
$690K ﹤0.01%
10,436
+1,345
+15% +$94.6K
ALHC icon
1615
Alignment Healthcare
ALHC
$2.8B
$690K ﹤0.01%
61,344
+3,256
+6% +$38.1K
NTLA icon
1616
Intellia Therapeutics
NTLA
$1.66B
$690K ﹤0.01%
59,187
+3,491
+6% +$54.5K
CIM
1617
Chimera Investment
CIM
$991M
$689K ﹤0.01%
49,231
+2,694
+6% +$40.4K
AORT icon
1618
Artivion
AORT
$1.39B
$689K ﹤0.01%
24,103
+1,671
+7% +$46.4K
WINA icon
1619
Winmark
WINA
$1.26B
$689K ﹤0.01%
1,753
+99
+6% +$38.9K
DMC
1620
Del Monte Corp
DMC
$1.42B
$687K ﹤0.01%
20,684
+786
+4% +$25.2K
FA icon
1621
First Advantage
FA
$3.61B
$686K ﹤0.01%
36,606
+5,795
+19% +$110K
PDM
1622
Piedmont Realty Trust
PDM
$1.19B
$685K ﹤0.01%
74,903
+5,258
+8% +$51.1K
ARDX icon
1623
Ardelyx
ARDX
$1.01B
$685K ﹤0.01%
135,156
+10,213
+8% +$56.4K
GEAR
1624
DELISTED
Revelyst, Inc.
GEAR
$685K ﹤0.01%
+35,620
New +$679K
CNNE icon
1625
Cannae Holdings
CNNE
$675M
$684K ﹤0.01%
34,432
+1,883
+6% +$37.7K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.